Project Inform - April, 1998
| Protease Inhibitors | |||
| Initials | Generic name | Trade name | Manufacturer |
| AMP | amprenavir | n/a | Glaxo Wellcome |
| IDV | indinavir | Crixivan© | Merck |
| NFV | nelfinavir | Viracept© | Agouron |
| SQVhgc | saquinavir | Invirase© | Hoffman-La Roche |
|
SQVsgc soft gel capsule |
saquinavir (new) | Fortovase© | Hoffman-La Roche |
| RTV | ritonavir | Norvir© | Abbott Labs |
| NARTIs (Nucleoside Analogue Reverse Transcriptase Inhibitors) | |||
| Initials | Generic name | Trade name | Manufacturer |
| ABA | abacavir | Ziagen© | Glaxo Wellcome |
| ADF | adefovir | Preveon© | Gilead Sciences |
| AZT | zidovudine | Retrovir© | Glaxo Wellcome |
| ddC | zalcitabine | Hivid© | Hoffman-La Roche |
| ddI | didanosine | Videx© | Bristol-Myers Squibb |
| d4T | stavudine | Zerit© | Bristol-Myers Squibb |
| 3TC | lamivudine | Epivir© | Glaxo Wellcome |
| ATZ+3TC | n/a | Combivir© | Glaxo Wellcome |
| NNRTIs (Non-Nucleoside Reverse Transcriptase Inhibitors) | |||
| Initials | Generic name | Trade name | Manufacturer |
| EFV | efavirenz | Sustiva© | Dupont Merck |
| NVP | nevirapine | Viramune© | Boehringer Ingelheim |
| DLV | delavirdine | Rescriptor© | Pharmacia & Upjohn |
980401
PI980408
©1998. This document is copyrighted by Project Inform, 205 13th Street, #2001, San Francisco, CA 94103. Treatment Hotline: 800-822-7422 (toll-free) or 415-558-9051 (in the San Francisco Bay Area and internationally) All Project Inform materials may be reprinted and/or distributed without prior permission. However, reprints may not be edited and must include the following text: "From Project Inform, for more information contact the Project Inform National HIV/AIDS Treatment Hotline, 800-822-7422." For permission to edit any Project Inform material for further publication, contact David Evans at the Project Inform office.
Project Inform, established in 1985 as a national, non profit, community-based HIV/AIDS treatment information and advocacy organization, serves HIV-infected individuals, their care-givers, and their healthcare and service providers through its national, toll-free treatment hotline, the PI Perspective and other information publications, educational Town Meetings, on-line services and research and drug access advocacy programs. All information is available free of charge; donations are strongly encouraged. For more information, contact the Project Inform National HIV/AIDS Treatment Hotline. Email: web@projinf.org; Website: http://www.projinf.org.
The original of this article can be found at http://www.projinf.org/pub/24/lowerdose.html